drugset / Trial / NCT00226460

Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

NCT00226460 ↗

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo treatment.

Timeline

Start
1997-08
Primary completion
—
Completion
2001-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Neurocell-PD Unknown — —

Indications